| abstract |
The present invention provides a compound having a novel structure, low side effects, excellent human SGLT1 and/or SGLT2 inhibitory activity, or a pharmaceutically acceptable salt thereof, and the like as an active ingredient for treating and/or preventing diabetes and the like. Pharmaceutical composition. The solution of the present invention is to provide a compound of the formula (I) or a pharmaceutically acceptable salt thereof, and the formula (I) is as follows: |